Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice

Clinical and Vaccine Immunology

Volumn 15, Issue 3, 2008, Pages 474-483

  Beamer, Gillian L ^a   Flaherty, David K ^b   Vesosky, Bridget ^a   Turner, Joanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BLOOD CULTURE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; IMMUNE RESPONSE; INCIDENCE; INFECTION RISK; INFECTION SENSITIVITY; INTERFERON PRODUCTION; MOUSE; MOUSE STRAIN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SUPERNATANT; TUBERCULOSIS; ANIMAL; BLOOD; C3H MOUSE; C57BL MOUSE; CBA MOUSE; DBA MOUSE; EVALUATION; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; LUNG; LUNG TUBERCULOSIS; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DISEASE PROGRESSION; FEMALE; HUMANS; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED DBA; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; SPECIFIC PATHOGEN-FREE ORGANISMS; TUBERCULOSIS, PULMONARY;

EID: 42049115724     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00408-07     Document Type: Article

References (63)

1. Andersen, P., T. M. Doherty, M. Pai, and K. Weldingh. 2007. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol. Med. 13:175-182.
2. Boussiotis, V. A., E. Y. Tsai, E. J. Yunis, S. Thim, J. C. Delgado, C. C. Dascher, A. Berezovskaya, D. Rousset, J.-M. Reynes, and A. E. Goldfeld. 2000. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Investig. 105:1317-1325.
3. Brandt, L., T. Oettinger, A. Holm, A. B. Andersen, and P. Andersen. 1996. Key epitopes on the ESAT-6 antigen recognized in mice during recall of protective immunity to Mycobacterium tuberculosis. J. Immunol. 157:3527-3533.
4. Cardona, P.-J., S. Gordillo, J. Diaz, G. Tapia, I. Amat, A. Pallares, C. Vilaplana, A. Ariza, and V. Ausina. 2003. Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 71:5845-5854.
5. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162:5407-5416.
6. Casanova, J.-L., and L. Abel. 2002. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20:581-620.
7. Chackerian, A. A., J. M. Alt, T. V. Perera, C. C. Dascher, and S. M. Behar. 2002. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70:4501-4509.
8. + T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69:2666-2674.
9. Chee, C. B. E., K. W. KhinMar, S. H. Gan, T. M. S. Barkham, M. Pushparani, and Y. T. Wang. 2007. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am. J. Respir. Crit. Care Med. 175:282-287.
10. Cooper, A., D. Dalton, T. Stewart, J. Griffin, D. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-gamma gene-disrupted mice. J. Exp. Med. 178:2243.
11. Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009-1021.
12. Dannenburg, A., and F. Collins. 2001. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis 81:229-242.
13. Delgado, J. C., E. Y. Tsai, S. Thim, A. Baena, V. A. Boussiotis, J.-M. Reynes, S. Sath, P. Grosjean, E. J. Yunis, and A. E. Goldfeld. 2002. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc. Natl. Acad. Sci. USA 99:7576-7581.
14. Demissie, A., M. Abebe, A. Aseffa, G. Rook, H. Fletcher, A. Zumla, K. Weldingh, I. Brock, P. Andersen, and T. M. Doherty. 2004. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4δ2. J. Immunol. 172:6938-6943.
15. Desai, S. B., and D. E. Furst. 2006. Problems encountered during antitumour necrosis factor therapy. Best Pract. Res. Clin. Rheumatol. 20:757-790.
16. Dheda, K., A. Pooran, M. Pai, R. F. Miller, K. Lesley, H. L. Booth, G. M. Scott, A. N. Akbar, and G. A. Rook. 2007. Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J. Infect. 55:169-173.
17. Dietrich, J., C. Aagaard, R. Leah, A. W. Olsen, A. Stryhn, T. M. Doherty, and P. Andersen. 2005. Exchanging ESAT-6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT-6-based sensitive monitoring of vaccine efficacy. J. Immunol. 174:6332-6339.
18. Dogra, S., P. Narang, D. K. Mendiratta, P. Chaturvedi, A. L. Reingold, J. M. Colford, Jr., L. W. Riley, and M. Pai. 2007. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J. Infect. 54:267-276.
19. Doherty, T. M., A. Demissie, J. Olobo, D. Wolday, S. Britton, T. Eguale, P. Ravn, and P. Andersen. 2002. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol. 40:704-706.
20. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
21. Hill, P., A. Fox, D. Jeffries, D. Jackson-Silah, M. Lugos, M. Owiafe, S. Donkor, A. Hammond, T. Corrah, R. Adegbola, and K. McAdam. 2005. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin. Infect. Dis. 40:273-278.
22. Hurwitz, A. A., T. F.-Y. Yu, D. R. Leach, and J. P. Allison. 1998. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma. Proc. Natl. Acad. Sci. USA 95:10067-10071.
23. Jagannath, C., H. Hoffmann, E. Sepulveda, J. K. Actor, R. A. Wetsel, and R. L. Hunter, Jr. 2000. Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand. J. Immunol. 52:369-379.
24. Jamil, B., F. Shaid, Z. Hasan, N. Nasir, T. Razzaki, G. Dawood, and R. Hussain. 2007. Interferon-gamma/IL-10 ratio defines disease severity in pulmonary and extra-pulmonary tuberculosis. Tuberculosis 87:279-287.
25. Janssens, J.-P., P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, and T. Rochat. 2007. Quantitative scoring of a gamma-interferon assay for differentiating active from latent tuberculosis. Eur. Respir. J. 30:722-728.
26. Leyten, E. M., S. M. Arend, C. Prins, F. G. Cobelens, T. H. M. Ottenhoff, and J. T. van Dissel. 2007. Discrepancy between Mycobacterium tuberculosis-specific interferon-gamma release assays using short versus prolonged in vitro incubation. Clin. Vaccine Immunol. 7:800-805.
27. Lyadova, I., E. Eruslanov, S. Khaidukov, V. Yeremeev, K. Majorov, A. Pichugin, B. V. Nikonenko, T. Kondratieva, and A. S. Apt. 2000. Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistent to M. tuberculosis triggered disease. J. Immunol. 165:5921-5931.
28. Lyadova, I., V. Yeremeev, M. Konstantin, B. Nikonenko, S. Khaidukov, T. Kondratieva, N. Kobets, and A. Apt. 1998. An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect. Immun. 66:4981-4988.
29. Medina, E., and R. North. 1999. Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination. Immunology 96:16-21.
30. Medina, E., and R. J. North. 1998. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 93:270-274.
31. Menzies, D., M. Pai, and G. Comstock. 2007. Meta-analysis. New tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146:340-354.
32. Millington, K. A., J. A. Innes, S. Hackforth, T. S. Hinks, J. J. Deeks, D. Dosanjh, V. Guyot-Revol, R. Gunatheesan, P. Klenerman, and A. Lalvani. 2007. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178:5217-5226.
33. Moore, K. W., R. de Wall Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
34. Orme, I. M. 1987. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate T lymphocytes. J. Immunol. 138:4414-4418.
35. Orme, I. M. 1995. Mechanisms underlying the increased susceptibility of aged mice to tuberculosis. Nutr. Rev. 53:S35-S40.
36. Pai, M., K. Dheda, J. Cunningham, F. Scano, and R. O'Brien. 2007. T-cell assay for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect. Dis. 7:428-438.
37. Pai, M., K. Gokhale, R. Joshi, S. Dogra, S. Kalantri, D. K. Mendiratta, P. Narang, C. L. Daley, R. M. Granich, G. H. Mazurek, A. L. Reingold, L. W. Riley, and J. M. Colford, Jr. 2005. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon γ assay with tuberculin skin testing. JAMA 293:2746-2755.
38. Pai, M., R. Joshi, M. Bandyopadhyay, P. Narang, S. Dogra, B. Taksande, and S. Kalantri. 2007. Sensitivity of whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis drug treatment. Infection 35:98-103.
39. Pai, M., R. Joshi, S. Dogra, D. K. Mendiratta, P. Narang, K. Dheda, and S. Kalantri. 2006. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J. Occup. Med. Toxicol. 1:1-7.
40. Pai, M., R. Joshi, S. Dogra, D. K. Mendiratta, P. Narang, S. Kalantri, A. L. Reingold, J. M. Colford, Jr., L. W. Riley, and D. Menzies. 2006. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am. J. Respir. Crit. Care Med. 174:349-355.
41. Pai, M., S. Kalantri, and K. Dheda. 2006. New tools and emerging technologies for the diagnosis of tuberculosis. Part I. Latent tuberculosis. Exp. Rev. Mol. Diagn. 6:413-422.
42. Pai, M., and D. Menzies. 2007. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin. Infect. Dis. 44:74-77.
43. Pathan, A. A., K. A. Wilkinson, P. Klenerman, H. McShane, R. N. Davidson, G. Pasvol, A. V. S. Hill, and A. Lalvani. 2001. Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167:5217- 5225.
44. Pierce, C., R. Dubos, and G. Middlebrook. 1947. Infection of mice with mammalian tubercle bacilli grown in Tween-albumin liquid medium. J. Exp. Med. 86:159-174.
45. Ravn, P., A. Demissie, T. Eguale, H. Wondwosson, D. Lein, H. A. Amoudy, A. S. Mustafa, A. K. Jensen, A. Holm, I. Rosenkrands, F. Oftung, J. Olobo, and F. von Reyn. 1999. Human T cell responses to ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179:637-645.
46. Rogerson, B. J., Y.-J. Jung, R. LaCourse, L. Ryan, N. Enright, and R. J. North. 2006. Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice. Immunology 118:195-201.
47. Roque, S., C. Nobrega, R. Appelberg, and M. Corrcia-Neves. 2007. IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. J. Immunol. 178:8028-8035.
48. Sable, S. B., D. Goyal, I. Verma, D. Behera, and G. K. Khuller. 2007. Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins. Eur. Respir. J. 29:337-346.
49. Sahiratmadja, E., B. Alisjahbana, T. de Boer, I. Adnan, A. Maya, H. Danusantoso, R. H. H. Newlan, S. Marzuki, J. W. M. van der Meer, R. van Crevel, E. van de Vosse, and T. H. M. Ottenhoff. 2007. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signalling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect. Immun. 75:820-829.
50. Schurr, E. 2007. Is susceptibility to tuberculosis acquired or inherited? J. Intern. Med. 261:106-111.
51. Sepkowitz, K. A., J. Raffalli, L. Riley, T. E. Kiehn, and D. Armstrong. 1995. Tuberculosis in the AIDS era. Clin. Microbiol. Rev. 1995:2.
52. Silva, R. A., T. F. Pais, and R. Appelberg. 2001. Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination. J. Immunol. 167:1535-1541.
53. Turner, J., M. Gonzalez-Juarrero, D. L. Ellis, R. J. Basaraba, A. Kipnis, I. M. Orme, and A. M. Cooper. 2002. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6J mice. J. Immunol. 169:6343-6351.
54. Turner, J., M. Gonzalez-Juarrero, B. M. Saunders, J. V. Brooks, P. Marietta, D. L. Ellis, A. A. Frank, and I. M. Orme. 2001. Immunological basis for reactivation of tuberculosis in mice. Infect. Immun. 69:3264-3270.
55. Turner, O. C., R. Keefe, I. Sugawara, H. Yamanda, and I. M. Orme. 2003. SWR mice are highly susceptible to pulmonary infection with Mycobacterium tuberculosis. Infect. Immun. 71:5266-5277.
56. Ulrichs, T., P. Anding, S. A. Porcelli, S. A. Kaufmann, and M. E. Munk. 2000. Increased numbers of ESAT-6 and purified protein derivative-specific gamma-interferon-producing cells in subclinical and active tuberculosis infection. Infect. Immun. 68:6073-6076.
57. Vervenne, R. A. W., S. L. Jones, D. van Soolingen, T. van der Laan, P. Andersen, P. J. Heidt, A. W. Thomas, and J. A. M. Langermanns. 2004. TB diagnosis in non-human primates: comparison of two interferon-gamma assays and the skin test for identification of Mycobacterium tuberculosis infection. Vet. Immunol. Immunopathol. 100:61-71.
58. Vesosky, B., D. K. Flaherty, E. K. Rottinghaus, G. L. Beamer, and J. Turner. 2006. Age dependent increase in early resistance of mice to Mycobacterium tuberculosis is associated with an increase in CD8 T cells that are capable of antigen independent IFN-gamma production. Exp. Gerontol. 41:1185-1194.
59. Vordermeier, H. M., M. A. Chambers, P. J. Cockle, A. O. Whelan, J. Simmons, and R. G. Hewinson. 2002. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70:3026-3032.
60. WHO. 2005. Report: global tuberculosis control-surveillance, planning, financing. http://www.who.int/tb/publications/global_report/2005.
61. WHO. 2005. Report: tuberculosis fact sheet number 104. http://www.who.int/mediacentre/factsheets/fs104/en/print.html.
62. Winslow, G. M., A. D. Roberts, M. A. Blackman, and D. L. Woodland. 2003. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170:2046-2052.
63. Winthrop, K. 2006. Risk and prevention of tuberculosis and other serious opportunistic infection associated with the inhibition of tumor necrosis factor. Nat. Clin. Pract. Rheumatol. 2:602-610.